重新思考差异化甲状腺癌的预后模型
Liang He1, Jingzhe Xiang1, Hao Zhang1
1Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.
Frontiers in endocrinology
|October 15, 2024
概括
对差异化甲状腺癌 (DTC) 的新分期系统改善了癌症特异性存活率 (CSS) 的预测. 这种精细的TNM分期系统为DTC患者提供了更准确的风险分层.
科学领域:
- 在瘤学瘤学.
- 医疗分期系统 医疗分期系统
- 癌症生存预测的预测
背景情况:
- 目前对差异化甲状腺癌 (DTC) 的长期癌症特异性生存率 (CSS) 预测不足以指导治疗.
- 需要完善现有的分期系统,以提高与DTC患者生存结果相关的准确性.
研究的目的:
- 开发和验证差异化甲状腺癌 (DTC) 的新型分期系统,以提高癌症特异性存活率 (CSS) 的预测.
- 改善DTC患者的风险分层和治疗选择.
主要方法:
- 对监测,流行病学和最终结果 (SEER) 数据库 (2004-2020) 的回顾性分析.
- 使用培训队列 (2004-2015) 开发决策树分类模型,并在单独的队列中进行验证 (2016-2020).
- 包括五个关键变量:M类,年龄,甲状腺外延伸,瘤大小和N类.
主要成果:
- 新系统将52,917名 (培训) 和48,896名 (验证) DTC 患者分为五个TNM组,在组内具有相似的CSS.
- 与第八个TNM系统相比,改进后的系统显示出更高比例的解释差异 (5.04%) 和较低的Akaike信息标准 (18,331,906).
- 新的DTC分期系统在验证队列中改善了生存歧视.
结论:
- 开发的分期系统为区分DTC死亡风险提供了更准确的方法.
- 这种精细的系统提供了增强的风险分层,可能导致差异化甲状腺癌患者更精确的治疗选择.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328